Bernard L. Zidar
-
- Occupational and environmental lung diseases 5
- Lung Cancer Treatments and Mutations 3
- Sarcoma Diagnosis and Treatment 2
- Hematology top 10%
-
- Chronic Lymphocytic Leukemia Research 3
-
- Neuroblastoma Research and Treatments 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Glycosylation and Glycoproteins Research 2
-
- Soft tissue tumor case studies 2
- Co-authors
- Richard K. ShadduckAlan WinkelsteinZella R. ZeiglerStanley P. BalcerzakH. Irving PierceM KeatingDavid FriedlandJonathan E. Cohen
- Journals
- Cancer (6 papers)American Journal of Hematology (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Bernard L. Zidar
22 papers receiving 591 citations
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 345
- Hematology 80
- Oncology 170
- Genetics 52
- Nutrition and Dietetics 66
Countries citing papers authored by Bernard L. Zidar
This map shows the geographic impact of Bernard L. Zidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard L. Zidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard L. Zidar more than expected).
Fields of papers citing papers by Bernard L. Zidar
This network shows the impact of papers produced by Bernard L. Zidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard L. Zidar. The network helps show where Bernard L. Zidar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernard L. Zidar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. | 1999 | 126 |
| 2 | 1995 | 5 | |
| 3 | 1995 | 9 | |
| 4 | 1992 | 34 | |
| 5 | Mucin-positive epithelial mesothelioma. | 1992 | 31 |
| 6 | 1990 | 1 | |
| 7 | 1990 | 20 | |
| 8 | Normal pressure hydrocephalus in a patient with systemic lupus erythematosus. | 1990 | 9 |
| 9 | 1989 | 19 | |
| 10 | 1988 | 70 | |
| 11 | 1987 | 18 | |
| 12 | 1987 | 31 | |
| 13 | 1985 | 29 | |
| 14 | Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study. | 1983 | 15 |
| 15 | 1983 | 33 | |
| 16 | 1983 | 13 | |
| 17 | 1977 | 23 | |
| 18 | 1977 | 86 | |
| 19 | 1976 | 31 | |
| 20 | 1975 | 15 |
About Bernard L. Zidar
Bernard L. Zidar is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 22 papers that have together received 632 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Neuroblastoma Research and Treatments (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Glycosylation and Glycoproteins Research (2 papers), Soft tissue tumor case studies (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (345 citations), Hematology (80 citations) and Oncology (170 citations). Bernard L. Zidar has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Richard K. Shadduck, Alan Winkelstein, Zella R. Zeigler, Stanley P. Balcerzak, H. Irving Pierce, M Keating, David Friedland, Jonathan E. Cohen, BC Lembersky and Rachel Miller. Their work appears in journals such as Cancer, American Journal of Hematology, New England Journal of Medicine, American Journal of Clinical Pathology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.